Mark Flower
VP of Business Development, Cell and Gene Technologies,
AGC Biologics
Sessions
-
09-Sep-2026Theatre 1 (Zafir)Panel: Access is the real innovation: How Europe turns breakthroughs into therapies patients can actually receive